Thalidomide for the Treatment of Refractory Multiple Myeloma: Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
暂无分享,去创建一个
Y. Ikeda | Y. Tanigawara | T. Kamata | Taketo Yamada | S. Okamoto | H. Uchida | Kunihiko Morita | Y. Hattori | N. Takayama | Naoki Shimada | Masaya Yamaguchi | N. Sato | Tsunayuki Kakimoto